TMCI:NASDAQ
Treace Medical Concepts, Inc
US$1.86
arrow_upward
+2.76%(+0.050) 1 天
US$1.89
arrow_upward
+1.61% (+0.030)bedtime盘后交易
休市： 5月1日, GMT-4 16:00:00 · USD
search
所有股票代码
1 天
5 天
1 个月
6 个月
年初至今
1 年
5 年
最大
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 TMCI 生成关键数据洞见…
开盘价
US$1.82
最高价
US$1.88
最低价
US$1.74
市值
一.二〇亿
平均成交量
八八.六五万
成交量
三三.〇〇万
52 周最高价
US$7.78
52 周最低价
US$1.17
每股收益
-US$0.93
Beta 版
〇.八八
流通股数
六四七八.四〇万
员工人数
四五〇
新闻报道
来自全网
资料
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Treace Medical Concepts, Inc简介